Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 340

1.

Gut Vibes in Parkinson's Disease: The Microbiota-Gut-Brain Axis.

Bullich C, Keshavarzian A, Garssen J, Kraneveld A, Perez-Pardo P.

Mov Disord Clin Pract. 2019 Oct 23;6(8):639-651. doi: 10.1002/mdc3.12840. eCollection 2019 Nov. Review.

PMID:
31745471
2.

Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.

Bishehsari F, Engen PA, Voigt RM, Swanson G, Shaikh M, Wilber S, Naqib A, Green SJ, Shetuni B, Forsyth CB, Saadalla A, Osman A, Hamaker BR, Keshavarzian A, Khazaie K.

Cell Mol Gastroenterol Hepatol. 2019 Nov 2. pii: S2352-345X(19)30147-X. doi: 10.1016/j.jcmgh.2019.10.011. [Epub ahead of print]

3.

Microbes help to track time.

Bishehsari F, Keshavarzian A.

Science. 2019 Sep 27;365(6460):1379-1380. doi: 10.1126/science.aaz0224. No abstract available.

PMID:
31604257
4.

Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot study.

Moossavi S, Engen PA, Ghanbari R, Green SJ, Naqib A, Bishehsari F, Merat S, Poustchi H, Keshavarzian A, Malekzadeh R.

BMC Microbiol. 2019 Jun 28;19(1):145. doi: 10.1186/s12866-019-1519-2.

5.

Alcohol Effects on Colon Epithelium are Time-Dependent.

Bishehsari F, Zhang L, Voigt RM, Maltby N, Semsarieh B, Zorub E, Shaikh M, Wilber S, Armstrong AR, Mirbagheri SS, Preite NZ, Song P, Stornetta A, Balbo S, Forsyth CB, Keshavarzian A.

Alcohol Clin Exp Res. 2019 Sep;43(9):1898-1908. doi: 10.1111/acer.14141. Epub 2019 Jul 22.

PMID:
31237690
6.

The Combination of 2'-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice.

Xiao L, Engen PA, Leusink-Muis T, van Ark I, Stahl B, Overbeek SA, Garssen J, Naqib A, Green SJ, Keshavarzian A, Folkerts G, Van't Land B.

J Nutr. 2019 May 1;149(5):856-869. doi: 10.1093/jn/nxz006.

7.

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.

Garrett-Bakelman FE, Darshi M, Green SJ, Gur RC, Lin L, Macias BR, McKenna MJ, Meydan C, Mishra T, Nasrini J, Piening BD, Rizzardi LF, Sharma K, Siamwala JH, Taylor L, Vitaterna MH, Afkarian M, Afshinnekoo E, Ahadi S, Ambati A, Arya M, Bezdan D, Callahan CM, Chen S, Choi AMK, Chlipala GE, Contrepois K, Covington M, Crucian BE, De Vivo I, Dinges DF, Ebert DJ, Feinberg JI, Gandara JA, George KA, Goutsias J, Grills GS, Hargens AR, Heer M, Hillary RP, Hoofnagle AN, Hook VYH, Jenkinson G, Jiang P, Keshavarzian A, Laurie SS, Lee-McMullen B, Lumpkins SB, MacKay M, Maienschein-Cline MG, Melnick AM, Moore TM, Nakahira K, Patel HH, Pietrzyk R, Rao V, Saito R, Salins DN, Schilling JM, Sears DD, Sheridan CK, Stenger MB, Tryggvadottir R, Urban AE, Vaisar T, Van Espen B, Zhang J, Ziegler MG, Zwart SR, Charles JB, Kundrot CE, Scott GBI, Bailey SM, Basner M, Feinberg AP, Lee SMC, Mason CE, Mignot E, Rana BK, Smith SM, Snyder MP, Turek FW.

Science. 2019 Apr 12;364(6436). pii: eaau8650. doi: 10.1126/science.aau8650.

PMID:
30975860
8.

Hepatic Inactivation of the Type 2 Deiodinase Confers Resistance to Alcoholic Liver Steatosis.

Fonseca TL, Fernandes GW, Bocco BMLC, Keshavarzian A, Jakate S, Donohue TM Jr, Gereben B, Bianco AC.

Alcohol Clin Exp Res. 2019 Jul;43(7):1376-1383. doi: 10.1111/acer.14027. Epub 2019 Apr 26.

PMID:
30908637
9.

Circadian rhythms: a regulator of gastrointestinal health and dysfunction.

Voigt RM, Forsyth CB, Keshavarzian A.

Expert Rev Gastroenterol Hepatol. 2019 May;13(5):411-424. doi: 10.1080/17474124.2019.1595588. Epub 2019 Mar 25.

PMID:
30874451
10.

Hedgehog signaling keeps liver clock in check.

Mazzoccoli G, Keshavarzian A, Vinciguerra M.

J Hepatol. 2019 Jun;70(6):1054-1056. doi: 10.1016/j.jhep.2019.02.009. Epub 2019 Feb 28. No abstract available.

PMID:
30826121
11.

Physical Inaccessibility of a Resistant Starch Shifts Mouse Gut Microbiota to Butyrogenic Firmicutes.

Kaur A, Chen T, Green SJ, Mutlu E, Martin BR, Rumpagaporn P, Patterson JA, Keshavarzian A, Hamaker BR.

Mol Nutr Food Res. 2019 Apr;63(7):e1801012. doi: 10.1002/mnfr.201801012. Epub 2019 Jan 27.

PMID:
30659764
12.

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.

van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S.

Nat Commun. 2019 Jan 18;10(1):310. doi: 10.1038/s41467-019-08294-y.

13.

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A.

Neurobiol Dis. 2018 Dec 21:104352. doi: 10.1016/j.nbd.2018.12.012. [Epub ahead of print] Review.

14.

Effects of diet on the childhood gut microbiome and its implications for atopic dermatitis.

Mahdavinia M, Rasmussen HE, Botha M, Binh Tran TD, Van den Berg JP, Sodergren E, Davis E, Engen K, Gray C, Lunjani N, Hlela C, Preite NZ, Basera W, Hobane L, Watkins A, Engen P, Mankahla A, Gaunt B, Thomas F, Tobin MC, Landay A, Weinstock GM, Keshavarzian A, Levin ME.

J Allergy Clin Immunol. 2019 Apr;143(4):1636-1637.e5. doi: 10.1016/j.jaci.2018.11.034. Epub 2018 Dec 19. No abstract available.

PMID:
30578881
15.

Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.

Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A.

Gut. 2019 May;68(5):829-843. doi: 10.1136/gutjnl-2018-316844. Epub 2018 Dec 15.

16.

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.

Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J, Redegeld FA.

Front Immunol. 2018 Sep 20;9:2138. doi: 10.3389/fimmu.2018.02138. eCollection 2018.

17.

Chronotype, social jet lag, sleep debt and food timing in inflammatory bowel disease.

Chakradeo PS, Keshavarzian A, Singh S, Dera AE, Esteban JPG, Lee AA, Burgess HJ, Fogg L, Swanson GR.

Sleep Med. 2018 Dec;52:188-195. doi: 10.1016/j.sleep.2018.08.002. Epub 2018 Aug 17.

PMID:
30243610
18.

Sleep Quality in Ulcerative Colitis: Associations with Inflammation, Psychological Distress, and Quality of Life.

Hood MM, Wilson R, Gorenz A, Jedel S, Raeisi S, Hobfoll S, Keshavarzian A.

Int J Behav Med. 2018 Oct;25(5):517-525. doi: 10.1007/s12529-018-9745-9.

PMID:
30159665
19.

Association of nasal microbiome and asthma control in patients with chronic rhinosinusitis.

Yang HJ, LoSavio PS, Engen PA, Naqib A, Mehta A, Kota R, Khan RJ, Tobin MC, Green SJ, Schleimer RP, Keshavarzian A, Batra PS, Mahdavinia M.

Clin Exp Allergy. 2018 Dec;48(12):1744-1747. doi: 10.1111/cea.13255. Epub 2018 Sep 24. No abstract available.

20.

Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging.

Chen D, Xie R, Shu B, Landay AL, Wei C, Reiser J, Spagnoli A, Torquati A, Forsyth CB, Keshavarzian A, Sumner DR.

Ann N Y Acad Sci. 2019 Apr;1442(1):48-60. doi: 10.1111/nyas.13945. Epub 2018 Aug 12. Review.

PMID:
30101565
21.

Gut bacterial composition in a mouse model of Parkinson's disease.

Perez-Pardo P, Dodiya HB, Engen PA, Naqib A, Forsyth CB, Green SJ, Garssen J, Keshavarzian A, Kraneveld AD.

Benef Microbes. 2018 Sep 18;9(5):799-814. doi: 10.3920/BM2017.0202. Epub 2018 Aug 13.

PMID:
30099890
22.

Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.

Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, Walter J.

Microbiome. 2018 Jun 28;6(1):121. doi: 10.1186/s40168-018-0494-4.

23.

Nutraceuticals in colorectal cancer: A mechanistic approach.

Rossi M, Mirbagheri SEYEDS, Keshavarzian A, Bishehsari F.

Eur J Pharmacol. 2018 Aug 15;833:396-402. doi: 10.1016/j.ejphar.2018.06.027. Epub 2018 Jun 20. Review.

24.

Corrigendum to "Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain" [GENE 655 (2018) 1-12].

Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ.

Gene. 2019 Jan 5;680:105. doi: 10.1016/j.gene.2018.06.013. Epub 2018 Jun 12. No abstract available.

PMID:
29890121
25.

A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.

Dillon SM, Guo K, Austin GL, Gianella S, Engen PA, Mutlu EA, Losurdo J, Swanson G, Chakradeo P, Keshavarzian A, Landay AL, Santiago ML, Wilson CC.

AIDS. 2018 Jul 31;32(12):1599-1611. doi: 10.1097/QAD.0000000000001863.

26.

KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Bishehsari F, Zhang L, Barlass U, Preite NZ, Turturro S, Najor MS, Shetuni BB, Zayas JP, Mahdavinia M, Abukhdeir AM, Keshavarzian A.

Int J Cancer. 2018 Oct 15;143(8):1994-2007. doi: 10.1002/ijc.31592. Epub 2018 Aug 9.

27.

Summary of the 2017 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Hulsebus HJ, Curtis BJ, Molina PE, Afshar M, Boule LA, Morris N, Keshavarzian A, Kolls JK, Yeligar SM, Price ME, Wyatt TA, Choudhry MA, Kovacs EJ.

Alcohol. 2018 Jun;69:51-56. doi: 10.1016/j.alcohol.2017.10.006. Epub 2017 Oct 31.

28.

Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice.

Xiao L, Van't Land B, Engen PA, Naqib A, Green SJ, Nato A, Leusink-Muis T, Garssen J, Keshavarzian A, Stahl B, Folkerts G.

Sci Rep. 2018 Mar 1;8(1):3829. doi: 10.1038/s41598-018-22052-y.

29.

Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain.

Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ.

Gene. 2018 May 20;655:1-12. doi: 10.1016/j.gene.2018.02.048. Epub 2018 Feb 20. Erratum in: Gene. 2019 Jan 5;680:105.

PMID:
29474860
30.

Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis.

Bishehsari F, Engen PA, Preite NZ, Tuncil YE, Naqib A, Shaikh M, Rossi M, Wilber S, Green SJ, Hamaker BR, Khazaie K, Voigt RM, Forsyth CB, Keshavarzian A.

Genes (Basel). 2018 Feb 16;9(2). pii: E102. doi: 10.3390/genes9020102.

31.

The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients.

Mahdavinia M, Engen PA, LoSavio PS, Naqib A, Khan RJ, Tobin MC, Mehta A, Kota R, Preite NZ, Codispoti CD, Tajudeen BA, Schleimer RP, Green SJ, Keshavarzian A, Batra PS.

J Allergy Clin Immunol. 2018 Jul;142(1):287-290.e4. doi: 10.1016/j.jaci.2018.01.033. Epub 2018 Feb 13. No abstract available.

32.

Circadian Mechanisms in Alcohol Use Disorder and Tissue Injury.

Davis BT 4th, Voigt RM, Shaikh M, Forsyth CB, Keshavarzian A.

Alcohol Clin Exp Res. 2018 Apr;42(4):668-677. doi: 10.1111/acer.13612. Epub 2018 Mar 8. Review.

33.

Polyethylene Glycol-3350 (Miralax®)+1.9-L sports drink (Gatorade®)+2 tablets of bisacodyl results in inferior bowel preparation for colonoscopy compared with Polyethylene Glycol-Ascorbic Acid (MoviPrep®).

Khan MA, Patel KB, Nooruddin M, Swanson G, Fogg L, Keshavarzian A, Brown M.

Turk J Gastroenterol. 2018 Jan;29(1):67-74. doi: 10.5152/tjg.2018.17536.

34.

Colorectal Cancer and Alcohol Consumption-Populations to Molecules.

Rossi M, Jahanzaib Anwar M, Usman A, Keshavarzian A, Bishehsari F.

Cancers (Basel). 2018 Jan 30;10(2). pii: E38. doi: 10.3390/cancers10020038. Review.

35.

The Foxo1-Inducible Transcriptional Repressor Zfp125 Causes Hepatic Steatosis and Hypercholesterolemia.

Fernandes GW, Bocco BMLC, Fonseca TL, McAninch EA, Jo S, Lartey LJ, O-Sullivan I, Unterman TG, Preite NZ, Voigt RM, Forsyth CB, Keshavarzian A, Sinkó R, Goldfine AB, Patti ME, Ribeiro MO, Gereben B, Bianco AC.

Cell Rep. 2018 Jan 9;22(2):523-534. doi: 10.1016/j.celrep.2017.12.053.

36.

Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats.

Persons AL, Bradaric BD, Dodiya HB, Ohene-Nyako M, Forsyth CB, Keshavarzian A, Shaikh M, Napier TC.

PLoS One. 2018 Jan 2;13(1):e0190078. doi: 10.1371/journal.pone.0190078. eCollection 2018.

37.

Timing of food intake impacts daily rhythms of human salivary microbiota: a randomized, crossover study.

Collado MC, Engen PA, Bandín C, Cabrera-Rubio R, Voigt RM, Green SJ, Naqib A, Keshavarzian A, Scheer FAJL, Garaulet M.

FASEB J. 2018 Apr;32(4):2060-2072. doi: 10.1096/fj.201700697RR. Epub 2018 Jan 5.

38.

Complementary and Alternative Treatments Are Needed to Enhance the Care of the Inflammatory Bowel Disease Patient.

Keshavarzian A, Mutlu EA.

Gastroenterol Clin North Am. 2017 Dec;46(4):xiii-xiv. doi: 10.1016/j.gtc.2017.09.001. Epub 2017 Oct 5. No abstract available.

PMID:
29173532
39.

Diurnal variations in intestinal barrier integrity and liver pathology in mice: implications for alcohol binge.

Voigt RM, Forsyth CB, Shaikh M, Zhang L, Raeisi S, Aloman C, Preite NZ, Donohue TM Jr, Fogg L, Keshavarzian A.

Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G131-G141. doi: 10.1152/ajpgi.00103.2017. Epub 2017 Oct 26.

40.

Alcohol Feeding in Mice Promotes Colonic Hyperpermeability and Changes in Colonic Organoid Stem Cell Fate.

Forsyth CB, Shaikh M, Bishehsari F, Swanson G, Voigt RM, Dodiya H, Wilkinson P, Samelco B, Song S, Keshavarzian A.

Alcohol Clin Exp Res. 2017 Dec;41(12):2100-2113. doi: 10.1111/acer.13519. Epub 2017 Nov 7.

41.

Alcohol and Gut-Derived Inflammation.

Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, Keshavarzian A.

Alcohol Res. 2017;38(2):163-171. Review.

42.

CREB Protein Mediates Alcohol-Induced Circadian Disruption and Intestinal Permeability.

Davis BT 4th, Voigt RM, Shaikh M, Forsyth CB, Keshavarzian A.

Alcohol Clin Exp Res. 2017 Dec;41(12):2007-2014. doi: 10.1111/acer.13513. Epub 2017 Oct 30.

43.

Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.

Gianella S, Chaillon A, Mutlu EA, Engen PA, Voigt RM, Keshavarzian A, Losurdo J, Chakradeo P, Lada SM, Nakazawa M, Landay AL.

AIDS. 2017 Sep 24;31(15):2059-2067. doi: 10.1097/QAD.0000000000001579. Erratum in: AIDS. 2018 Aug 24;32(13):1911.

44.

Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Rasmussen HE, Hamaker B, Rajan KB, Mutlu E, Green SJ, Brown M, Kaur A, Keshavarzian A.

Nutr Res. 2017 Aug;44:27-37. doi: 10.1016/j.nutres.2017.05.015. Epub 2017 Jun 2.

45.

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.

Krarup AR, Abdel-Mohsen M, Schleimann MH, Vibholm L, Engen PA, Dige A, Wittig B, Schmidt M, Green SJ, Naqib A, Keshavarzian A, Deng X, Olesen R, Petersen AM, Benfield T, Østergaard L, Rasmussen TA, Agnholt J, Nyengaard JR, Landay A, Søgaard OS, Pillai SK, Tolstrup M, Denton PW.

Mucosal Immunol. 2018 Mar;11(2):449-461. doi: 10.1038/mi.2017.59. Epub 2017 Aug 2.

46.

Atopic dermatitis and food sensitization in South African toddlers: Role of fiber and gut microbiota.

Mahdavinia M, Rasmussen HE, Engen P, Van den Berg JP, Davis E, Engen K, Green SJ, Naqib A, Botha M, Gray C, Lunjani N, Hlela C, Basera W, Hobane L, Watkins A, Tobin MC, Landay A, Keshavarzian A, Levin ME.

Ann Allergy Asthma Immunol. 2017 Jun;118(6):742-743.e3. doi: 10.1016/j.anai.2017.04.011. No abstract available.

PMID:
28583264
47.

The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.

Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, Kraneveld AD.

Eur J Pharmacol. 2017 Dec 15;817:86-95. doi: 10.1016/j.ejphar.2017.05.042. Epub 2017 May 23. Review.

48.

Intestinal fungi contribute to development of alcoholic liver disease.

Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, Kisseleva T, Torralba MG, Moncera K, Beeri K, Chen CS, Freese K, Hellerbrand C, Lee SM, Hoffman HM, Mehal WZ, Garcia-Tsao G, Mutlu EA, Keshavarzian A, Brown GD, Ho SB, Bataller R, Stärkel P, Fouts DE, Schnabl B.

J Clin Invest. 2017 Jun 30;127(7):2829-2841. doi: 10.1172/JCI90562. Epub 2017 May 22.

49.

Increasing efficacy and reducing side effects in treatment of chronic anal fissures: A study of topical diazepam therapy.

Hang MTH, Smith BE, Keck C, Keshavarzian A, Sedghi S.

Medicine (Baltimore). 2017 May;96(20):e6853. doi: 10.1097/MD.0000000000006853.

50.

Evaluation of Diagnostic Values of Clinical Assessment in Determining the Maturation of Arteriovenous Fistulas for Satisfactory Hemodialysis.

Salimi F, Shahabi S, Talebzadeh H, Keshavarzian A, Pourfakharan M, Safaei M.

Adv Biomed Res. 2017 Mar 1;6:18. doi: 10.4103/2277-9175.201330. eCollection 2017.

Supplemental Content

Loading ...
Support Center